Vabysmo, a treatment for macular degeneration, can be prescribed at general hospitals.

According to related industries, Vabysmo, Roche Korea's first bispecific antibody treatment for eye diseases, passed the drug committee of medical institutions such as Konyang University Hospital, Kim Eye Clinic, Nune Eye Clinic, Inje University Busan Paik Hospital, and Chung-Ang University Hospital. Roche is also conducting landing procedures at medical institutions across the country. As Vabysmo is currently negotiating drug prices with NHIS, it is expected to be linked to actual prescriptions if it is listed on the insurance benefit list. Vabysmo, approved for the treatment of neovascular or wet age-related macula